Candel Therapeutics (CADL) News Today → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free CADL Stock Alerts $7.15 +0.03 (+0.42%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1, 2024 | marketbeat.comShort Interest in Candel Therapeutics, Inc. (NASDAQ:CADL) Drops By 19.4%Candel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 846,800 shares, a decrease of 19.4% from the April 30th total of 1,050,000 shares. Currently, 5.0% of the shares of the stock are sold short. Based on an average trading volume of 5,450,000 shares, the short-interest ratio is presently 0.2 days.May 30, 2024 | globenewswire.comFDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade GliomaMay 24, 2024 | markets.businessinsider.comCandel Reports Upbeat Data From Lung Cancer StudyMay 23, 2024 | globenewswire.comCandel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual MeetingMay 23, 2024 | baystreet.caBiotech Developers Pioneer New Treatments, Aiming to Reduce Pancreatic Cancer Fatalities in 2024May 22, 2024 | globenewswire.comCandel Therapeutics to Present at the Jefferies Global Healthcare ConferenceMay 20, 2024 | globenewswire.comCandel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual MeetingMay 16, 2024 | markets.businessinsider.comCandel Lights Up Investors' Portfolio With 830% GainMay 14, 2024 | investorplace.comCADL Stock Earnings: Candel Therapeutics Reported Results for Q1 2024May 14, 2024 | finance.yahoo.comCandel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsMay 14, 2024 | globenewswire.comCandel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsMay 11, 2024 | marketbeat.comCandel Therapeutics, Inc. (NASDAQ:CADL) Short Interest UpdateCandel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 1,050,000 shares, a decrease of 48.3% from the April 15th total of 2,030,000 shares. Currently, 6.7% of the shares of the stock are sold short. Based on an average trading volume of 5,290,000 shares, the short-interest ratio is currently 0.2 days.April 25, 2024 | globenewswire.comCandel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual MeetingApril 15, 2024 | seekingalpha.comCandel Therapeutics: CAN-2409 May Go Beyond Scope Of Targeting Pancreatic CancerApril 15, 2024 | marketbeat.comShort Interest in Candel Therapeutics, Inc. (NASDAQ:CADL) Grows By 9.2%Candel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 160,900 shares, an increase of 9.2% from the March 15th total of 147,300 shares. Currently, 1.0% of the company's shares are short sold. Based on an average daily trading volume, of 3,880,000 shares, the days-to-cover ratio is currently 0.0 days.April 11, 2024 | markets.businessinsider.comCandel Therapeutics' CAN-2409 For Pancreatic Cancer Gets FDA Orphan Drug Designation; Stock UpApril 11, 2024 | markets.businessinsider.comWhy Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionApril 11, 2024 | marketwatch.comCandel Therapeutics Shares Leap Premarket on FDA Orphan-Drug DesignationApril 11, 2024 | globenewswire.comCandel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic CancerApril 9, 2024 | globenewswire.comCandel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid TumorsApril 6, 2024 | finance.yahoo.comRetail investors invested in Candel Therapeutics, Inc. (NASDAQ:CADL) up 320% last week, insiders too were rewardedApril 5, 2024 | benzinga.comWhat's Going On With Candel Therapeutics Stock On Friday?April 5, 2024 | msn.comCandel Therapeutics stock jumps as pancreatic cancer treatment shows promiseApril 5, 2024 | marketbeat.comTrading was temporarily halted for "CADL" at 12:04 PM with a stated reason of "LULD pause." Trading set to resume at 12:04 PM. April 5, 2024 | marketbeat.comTrading was temporarily halted for "CADL" at 11:04 AM with a stated reason of "LULD pause."April 5, 2024 | marketbeat.comTrading was temporarily halted for "CADL" at 10:04 AM with a stated reason of "LULD pause."April 5, 2024 | marketbeat.comTrading was temporarily halted for "CADL" at 10:04 AM with a stated reason of "LULD pause."April 5, 2024 | marketbeat.comTrading was temporarily halted for "CADL" at 09:04 AM with a stated reason of "LULD pause."April 5, 2024 | marketbeat.comUnusually High Volume Points to Upside in These StocksIf investing were easy, everybody would do it, and we would all be rich. But that isn't the case.April 5, 2024 | marketbeat.comUnusually High Volume Points to Upside in These StocksUnusually high volume is often a signal of higher price to come; this is a look at three stocks with recent volume spikes and a reason for the price to advance.April 4, 2024 | msn.comWhy Allurion Technologies Stock Is Racing HigherApril 4, 2024 | investing.comAfter-hours movers: SoFi Technologies, GameStop, and moreApril 4, 2024 | marketbeat.comTrading was temporarily halted for "CADL" at 03:04 PM with a stated reason of "LULD pause."April 4, 2024 | marketwatch.comCandel Therapeutics Shares Hit 52-Week High After Positive Trial DataApril 4, 2024 | markets.businessinsider.comCandel's CAN-2409 Shows Positive Trial Results In Non-Metastatic Pancreatic Cancer; Stock UpApril 4, 2024 | finance.yahoo.comAfter Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer StudyApril 4, 2024 | globenewswire.comCandel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic CancerApril 1, 2024 | msn.comMicro-Cap Cancer Focused Candel Therapeutics Highlights Encouraging Data From Brain Tumor ImmunotherapyMarch 28, 2024 | globenewswire.comCandel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade GliomaMarch 28, 2024 | investorplace.comCADL Stock Earnings: Candel Therapeutics Misses EPS for Q4 2023March 28, 2024 | benzinga.comRecap: Candel Therapeutics Q4 EarningsMarch 28, 2024 | globenewswire.comCandel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate HighlightsMarch 5, 2024 | globenewswire.comCandel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy CandidateFebruary 21, 2024 | benzinga.comCandel Therapeutics Stock (NASDAQ:CADL), Short Interest ReportFebruary 15, 2024 | marketbeat.comShort Interest in Candel Therapeutics, Inc. (NASDAQ:CADL) Declines By 10.9%Candel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 166,200 shares, a drop of 10.9% from the January 15th total of 186,600 shares. Approximately 1.1% of the shares of the stock are short sold. Based on an average daily volume of 537,800 shares, the short-interest ratio is presently 0.3 days.February 13, 2024 | markets.businessinsider.comCandel's Can-3110 Receives FDA Fast Track DesignationFebruary 13, 2024 | finanznachrichten.deCandel Therapeutics: CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade GliomaFebruary 13, 2024 | benzinga.comCandel Therapeutics Sets Stage For Success With Cancer-Fighting ImmunotherapiesFebruary 13, 2024 | msn.comKrystal Biotech, Candel, Edgewise gain after FDA fast track tagsFebruary 13, 2024 | finance.yahoo.comCAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma Get Candel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CADL and its competitors with MarketBeat's FREE daily newsletter. Email Address The new masters of energy (Ad)According to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune. Click here to get all the details. CADL Media Mentions By Week CADL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CADL News Sentiment▼1.920.74▲Average Medical News Sentiment CADL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CADL Articles This Week▼11▲CADL Articles Average Week Get Candel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CADL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LIFE News Today URGN News Today IOBT News Today DRRX News Today ALGS News Today MESO News Today PRME News Today SRRK News Today TSHA News Today PROK News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CADL) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored